- $576.92m
- $968.42m
- $3.77bn
Annual income statement for Hyster-Yale, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 3,076 | 3,548 | 4,118 | 4,308 | 3,769 |
| Cost of Revenue | |||||
| Gross Profit | 363 | 434 | 786 | 896 | 633 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 3,228 | 3,587 | 3,910 | 4,063 | 3,791 |
| Operating Profit | -152 | -39.1 | 209 | 245 | -22.1 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -155 | -62.4 | 181 | 219 | -42.9 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -183 | -71.6 | 128 | 144 | -58 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -173 | -74.1 | 126 | 142 | -60.1 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -173 | -74.1 | 126 | 142 | -60.1 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -7.58 | -4.38 | 7.24 | 8.88 | -1.99 |
| Dividends per Share |